Literature DB >> 449538

Relapsing polychondritis--report of ten cases.

J M Damiani, H L Levine.   

Abstract

Relapsing polychondritis is a rare disease of unknown etiology. There are approximately 211 reported cases in the world literature. This is a report of ten cases from the Cleveland Clinic Foundation. McAdam's diagnostic criteria for R.P. were reviewed and modified. For diagnosis, all patients had to have 1. at least three or more diagnostic criteria, histologic confirmation not necessary; 2. one or more of McAdam's signs with positive histologic confirmation; or 3. chondritis in two or more separate anatomic locations with response to steroids and/or Dapsone. Chondritis of the auricles (9/10 patients) and arthropathy (8/10 patients) are the most common presenting signs. Chondritis was also seen in the nose (6/10) and the upper respiratory tract involving the larynx and trachea (4/10). Cochlear and vestibular damage and ocular inflammation were each seen in 5/10 patients. Patients were treated with steroids and/or Dapsone. Both drugs were reliable in abating episodes of activity and in decreasing recurrences. These results further support Dapsone as an alternate form of treatment for RP.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 449538

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  89 in total

1.  Corneal autoimmunity in a patient with relapsing polychondritis.

Authors:  F W Albers; M H Majoor; R Van der Gaag
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

2.  Relapsing polychondritis in childhood: a rare observation studied by CT and MRI.

Authors:  M Oddone; P Tomà; A Taccone; G Hanau; A Delogu; G Gemme
Journal:  Pediatr Radiol       Date:  1992

3.  [Successful therapy with etanercept in relapsing polychondritis].

Authors:  C Schräder; J Lohmann
Journal:  Z Rheumatol       Date:  2010-06       Impact factor: 1.372

4.  Treatment of relapsing polychondritis with the TNF-alpha antagonist adalimumab.

Authors:  Tobias Lahmer; Andreas Knopf; Matthias Treiber; Uwe Heemann; Klaus Thuermel
Journal:  Clin Rheumatol       Date:  2010-05-22       Impact factor: 2.980

Review 5.  Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives.

Authors:  Antonio Vitale; Jurgen Sota; Donato Rigante; Giuseppe Lopalco; Francesco Molinaro; Mario Messina; Florenzo Iannone; Luca Cantarini
Journal:  Curr Rheumatol Rep       Date:  2016-01       Impact factor: 4.592

Review 6.  Aortic involvement in relapsing polychondritis: case-based review.

Authors:  Mustafa Erdogan; Sinem Nihal Esatoglu; Gulen Hatemi; Vedat Hamuryudan
Journal:  Rheumatol Int       Date:  2019-11-25       Impact factor: 2.631

7.  Total hearing loss and blindness caused by relapsing polychondritis and myelodysplastic syndrome.

Authors:  Bozena Coha; Ljubica Fustar-Preradovic; Sandra Sekelj; Alen Sekelj
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-07-17       Impact factor: 2.503

Review 8.  Relapsing polychondritis: a review.

Authors:  Aman Sharma; Karthik Gnanapandithan; Kusum Sharma; Susmita Sharma
Journal:  Clin Rheumatol       Date:  2013-07-26       Impact factor: 2.980

9.  Rare cause of bilateral sudden deafness.

Authors:  F I Vos; P Merkus; E B J van Nieuwkerk; E F Hensen
Journal:  BMJ Case Rep       Date:  2016-10-08

10.  Three Cases of Relapsing Polycondritis with Isolated Laryngotracheal Stenosis.

Authors:  Hamdi Taşlı; Hakan Birkent; Mustafa Gerek
Journal:  Turk Arch Otorhinolaryngol       Date:  2017-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.